Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Y Lacourciere

Showing results (1-10 of 14) with videos related to

Pageof 2
Sort By:
The American Journal of Medicine|January 29, 1988
Analysis of well-being and 24-hour blood pressure recording in a comparative study between indapamide and captoprilY Lacourciere
Current Hypertension Reports|September 12, 2000
Chronotherapeutics: are there meaningful differences among antihypertensive drugs?L Poirier, J Lefebvre, Y Lacourciere
The Journal of Rheumatology|June 1, 1985
Radionuclide esophageal transit in progressive systemic sclerosisS Carette, Y Lacourciere, S Lavoie, et al.
The American Journal of Physiology|November 1, 1992
Baroreflex regulation of forearm vascular resistance after exercise in hypertensive and normotensive humansJ Cléroux, N Kouamé, A Nadeau, et al.
The New England Journal of Medicine|March 20, 1998
The effect of an endothelin-receptor antagonist, bosentan, on blood pressure in patients with essential hypertension. Bosentan Hypertension InvestigatorsH Krum, R J Viskoper, Y Lacourciere, et al.
Journal of Steroid Biochemistry|November 1, 1986
Advantages of the combination therapy in previously untreated and treated patients with advanced prostate cancerF Labrie, A Dupont, M Giguere, et al.
British Journal of Urology|April 1, 1988
Benefits of combination therapy with flutamide in patients relapsing after castrationF Labrie, A Dupont, M Giguere, et al.
British Journal of Urology|June 1, 1989
Anti-hormone treatment for prostate cancer relapsing after treatment with flutamide and castration. Addition of aminoglutethimide and low dose hydrocortisone to combination therapyF Labrie, A Dupont, A Bélanger, et al.
Progress in Clinical and Biological Research|January 1, 1988
Combination therapy with flutamide and castration (orchiectomy or LHRH agonist): the minimal endocrine therapy in both untreated and previously treated patients with advanced prostate cancerF Labrie, A Dupont, M Giguère, et al.
Journal of Steroid Biochemistry|January 1, 1987
Combination therapy with flutamide and castration (orchiectomy or LHRH agonist): the minimal endocrine therapy in both untreated and previously treated patientsF Labrie, A Dupont, M Giguere, et al.
Pageof 2

Showing results (1-10 of 14) with videos related to

Sort By:
Pageof 2
The American Journal of Medicine|January 29, 1988
Analysis of well-being and 24-hour blood pressure recording in a comparative study between indapamide and captoprilY Lacourciere
Current Hypertension Reports|September 12, 2000
Chronotherapeutics: are there meaningful differences among antihypertensive drugs?L Poirier, J Lefebvre, Y Lacourciere
The Journal of Rheumatology|June 1, 1985
Radionuclide esophageal transit in progressive systemic sclerosisS Carette, Y Lacourciere, S Lavoie, et al.
The American Journal of Physiology|November 1, 1992
Baroreflex regulation of forearm vascular resistance after exercise in hypertensive and normotensive humansJ Cléroux, N Kouamé, A Nadeau, et al.
The New England Journal of Medicine|March 20, 1998
The effect of an endothelin-receptor antagonist, bosentan, on blood pressure in patients with essential hypertension. Bosentan Hypertension InvestigatorsH Krum, R J Viskoper, Y Lacourciere, et al.
Journal of Steroid Biochemistry|November 1, 1986
Advantages of the combination therapy in previously untreated and treated patients with advanced prostate cancerF Labrie, A Dupont, M Giguere, et al.
British Journal of Urology|April 1, 1988
Benefits of combination therapy with flutamide in patients relapsing after castrationF Labrie, A Dupont, M Giguere, et al.
British Journal of Urology|June 1, 1989
Anti-hormone treatment for prostate cancer relapsing after treatment with flutamide and castration. Addition of aminoglutethimide and low dose hydrocortisone to combination therapyF Labrie, A Dupont, A Bélanger, et al.
Progress in Clinical and Biological Research|January 1, 1988
Combination therapy with flutamide and castration (orchiectomy or LHRH agonist): the minimal endocrine therapy in both untreated and previously treated patients with advanced prostate cancerF Labrie, A Dupont, M Giguère, et al.
Journal of Steroid Biochemistry|January 1, 1987
Combination therapy with flutamide and castration (orchiectomy or LHRH agonist): the minimal endocrine therapy in both untreated and previously treated patientsF Labrie, A Dupont, M Giguere, et al.
Pageof 2